Baron M, Tiraby G, Calmels T, Parriche M, Durand H
Laboratoire de Microbiologie et Génétique appliquées du CNRS, CRBGC, Université Paul Sabatier, Toulouse, France.
J Biotechnol. 1992 Jul;24(3):253-66. doi: 10.1016/0168-1656(92)90035-8.
Tolypocladium geodes strain NC50 was transformed by different integrating vectors bearing both a synthetic gene encoding human lysozyme (HLz) and the Sh ble phleomycin resistance marker, either in separate expression cassettes or in transcriptional or translational fusion configurations. Clones derived from all vectors were able to secrete HLz. The highest productivities in shake flasks (up to 150 mg l-1 in 5 days) were obtained when HLz was fused at the C-terminal end of the Sh ble protein. The fusion protein is efficiently secreted and release of active lysozyme occurs by extracellular proteolytic cleavage in the junction peptide.
用携带编码人溶菌酶(HLz)的合成基因和Sh ble博来霉素抗性标记的不同整合载体转化地生拟青霉菌株NC50,这些载体的基因分别位于不同的表达盒中,或呈转录或翻译融合构型。所有载体衍生的克隆都能够分泌HLz。当HLz融合在Sh ble蛋白的C末端时,摇瓶中的产量最高(5天内可达150 mg l-1)。融合蛋白能有效分泌,活性溶菌酶通过连接肽中的细胞外蛋白水解切割而释放。